Standex International Q3 2025 Earnings Report

Standex International EPS Results

• Actual EPS: $1.95
• Consensus EPS: $1.92
• Beat/Miss: Beat by +$0.03
• One Year Ago EPS: $1.75

Standex International Revenue Results

• Actual Revenue: $207.78 million
• Expected Revenue: $203.71 million
• Beat/Miss: Beat by +$4.07 million
• YoY Revenue Growth: +17.20%

Standex International Announcement Details

• Quarter: Q3 2025
• Date: 5/1/2025
• Time: After Market Closes
• Conference Call Date: Friday, May 2, 2025
• Conference Call Time: 8:30AM ET

Standex International (NYSE:SXI), together with subsidiaries, engages in the manufacture and sale of various products and services for commercial and industrial markets in the United States and internationally. It operates through five segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The Electronics segment offers reed relays, fluid level, proximity, motion, flow, HVAC condensate, and custom electronics sensors; and custom wound transformers and inductors for low and high frequency, current sense technology, advanced planar transformer technology, value added assembly, and mechanical packaging applications under the Standex Electronics, Renco, and Agile Magnetics. The Engraving segment provides mold texturizing, slush molding tools, roll engraving, hygiene product tooling, and low observation vents, as well as project management and design services for stealth aircraft; and process machinery for various industries under the Piazza Rosa, World Client Services, Tenibac-Graphion, GS Engineering, and Innovent brand names. The Scientific segment offers temperature-controlled equipment for the medical, scientific, pharmaceutical, biotech, and industrial markets under the American BioTech Supply, Lab Research Products, Corepoint, Cryosafe, CryoGuard, and Scientific brands. The Engineering Technologies segment offers net and near net formed single-source customized solutions that are used in the manufacture of engineered components for the aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and manned and unmanned space markets under the Spincraft brand. The Specialty Solutions segment manufactures and sells refrigerated, heated, and dry merchandizing display cases; and single and double acting telescopic, and piston rod hydraulic cylinders under the Federal and Custom Hoist brands. The company was founded in 1955 and is headquartered in Salem, New Hampshire.

Standex International Q3 2025 Earnings Call Transcript

Presentation

[Christopher Howe, Director of Investor Relations at Standex International]

Thank you, operator, and good morning. Please note that the presentation accompanying management's remarks can be found on the Investor Relations portion of the company's website at www.standex.com. Please refer to Standex's Safe Harbor statement on slide two. Matters that Standex management will discuss on today's conference call include predictions, estimates, expectations and other forward looking statements. These statements are subject to risks and uncertainties that could cause actual results to differ materially.

[Christopher Howe, Director of Investor Relations at Standex International]

You should refer to Standex's most recent annual report on Form 10 ks, as well as other SEC filings and public announcements, for a detailed list of risk factors. In addition, I'd like to remind you that today's discussion will include references to the non GAAP measures of EBIT, which is earnings before interest and taxes adjusted EBIT adjusted EBITDA and adjusted EBITDA margin. We will also refer to other non GAAP measures, including adjusted net income, adjusted operating income, adjusted net income from continuing operations, adjusted earnings per share, adjusted operating margin, pre operating cash flow, and pro form a net debt to EBITDA. Adjusted measures exclude the impact of restructuring, purchase accounting, amortization from acquired intangible assets, acquisition related expenses, and one time items. These non GAAP financial measures are intended to serve as a complement to results provided in accordance with accounting principles generally accepted in The United States.

[Christopher Howe, Director of Investor Relations at Standex International]

Believes that such information provides an additional measurement and consistent historical comparison of the company's financial performance. On the call today is Standex's Chairman, President and Chief Executive Officer, David Dunbar and Chief Financial Officer and Treasurer, Ademir Sarcevic.

[David Dunbar, Chairman, President & CEO at Standex International]

Thank you, Chris. Good morning and welcome to our fiscal third quarter twenty twenty five conference call. Following strong operating performance in the fiscal second quarter, we achieved several new records in our fiscal third quarter. These achievements include record sales since the divestiture of the refrigeration business in April 2020, record adjusted gross margin of 42.3% and record adjusted operating margin of 19.4%. Our growth engine continues to develop with sales into fast growing end markets representing a greater percentage of total sales.

[David Dunbar, Chairman, President & CEO at Standex International]

I'm also encouraged that new product sales are increasing above our projections and have added approximately 3% to our sales year to date. Once again, our teams have demonstrated their ability to navigate through difficult market conditions and deliver strong operating margins with price and productivity actions. Now if everyone can turn to Slide three key messages. In the third quarter, sales increased 17.2% with contributions from acquisitions partially offset by organic decline. Electronics book to bill was 0.98, indicating that markets are stable.

[David Dunbar, Chairman, President & CEO at Standex International]

And Electronics organic bookings were up more than 10% year on year. Sales from the Amarin and Orion Group were greater than $33,000,000 with book to bill of 1.04. The Amarin Narayan Group continues to perform ahead of our expectations. In the quarter, we made significant progress in planning expansions in India, Europe and The USA. In all regions, customer commitments extend years into the future and give us confidence to expand our existing facilities in India and The United States.

[David Dunbar, Chairman, President & CEO at Standex International]

At the request of the largest European electrical equipment OEMs, we are beginning work on a greenfield site in Europe and expect to be shipping product from that location by the end of our first quarter twenty twenty six, less than six months from now. Our fiscal third quarter sales into fast growth markets increased to 29% of total company sales. Sales into fast growth markets were primarily driven by electrical grid, commercialization of space, defense applications and renewable energy. New product sales totaled $13,400,000 in the fiscal third quarter, which doubled year on year, contributing approximately 3% to top line sales ahead of our goal of 2%. I'm especially pleased that we continue to demonstrate resilient operating performance from the execution of our price and productivity initiatives and from inorganic investments.

[David Dunbar, Chairman, President & CEO at Standex International]

As a result, we achieved record adjusted gross margin of 42.3%, up 140 basis points sequentially and two thirty basis points year on year and record adjusted operating margin of 19.4%, up 70 basis points sequentially and up two eighty basis points year on year. The integration of Amarin, Orion and McStarlight are progressing well. On a sequential basis, in fiscal fourth quarter twenty twenty five, we expect slightly to moderately higher revenue driven by the impact of recent acquisitions, higher sales into fast growth end markets and realization of pricing initiatives. We expect slightly to moderately higher adjusted operating margin due to higher revenue and realization of productivity actions, partially offset by tariff costs and targeted investments in selling, marketing and R and D. With three new products just released in the fiscal third quarter, we have released 13 products year to date, achieving our previously communicated target for over a dozen products in the fiscal year.

[David Dunbar, Chairman, President & CEO at Standex International]

Sales from new products are tracking ahead of expectations and are expected to contribute over 200 basis points of incremental growth. Now if everyone could turn to Slide four, tariff and inflation update. Before we discuss our fiscal third quarter in more detail, I would like to address the recent tariff announcements and how we are navigating their impact. Our customer intimacy business model requires that our plants are near customers, limiting exposure to tariff and trade disruptions. We have in region, for region operations and greater than 85% of our products are manufactured and sold within the same region.

[David Dunbar, Chairman, President & CEO at Standex International]

This serves as a natural buffer to any impact tariffs may have on economic activity. In addition, most of our customer relationships are based on a deep value proposition and long term partnership that typically only gets stronger during turbulent times positioning us well for the long term. To put another lens on this, imports of material inputs to U. S. Operations are a relatively small percentage of total cost of goods sold.

[David Dunbar, Chairman, President & CEO at Standex International]

Approximately 6% of our cost of goods sold are due to imports of materials to U. S. Operations from China. Approximately 4% are from India and approximately 3% are from other countries. We have started implementing additional productivity actions and select price increases and working to optimize our supply chain to mitigate the impact of tariffs.

[David Dunbar, Chairman, President & CEO at Standex International]

An intangible benefit of this uncertain economic environment is that our management teams around the world are coming together as they did in COVID to simultaneously protect margins, support strategic priorities and strengthen collaboration across the enterprise, a demonstration of our growing and strong culture. We plan to continue to invest in our key growth priorities and the new product developments as we work with customers on their next generation product platforms. We came out of the COVID downturn a much stronger company and I anticipate the same results during this disruption. We are confident in our agility, resilience and business by business execution over the short and long term to continue to deliver for our shareholders. Now if everyone can turn to Slide five, highlighting our recent acquisition.

[David Dunbar, Chairman, President & CEO at Standex International]

In early February, Standex acquired McStarlight, a leading provider of complex sheet metal aerospace components for $56,500,000 in cash. With facilities in Harbor City, California, McStarlight designs and manufacturers cold deep draw and bulge formed aviation components, including single piece lip skins, nozzles, complex metal assemblies and tooling to support production hardware. We have admired McStarlight for many years and this represented an ideal bolt on acquisition for engineering technologies. The integration has been seamless since its customer base, product line and technologies are highly complementary to our Spincraft business. We are excited about our expanded product breadth and forming capabilities in commercial aviation, space and defense applications.

[David Dunbar, Chairman, President & CEO at Standex International]

With the addition of McStarlight, the addressable market within engineering technologies expands by greater than $300,000,000 McStarlight enables expansion into wide body, military and MRO Lipskin segments and into space and defense sectors. Likewise, it expands SpinCraft's Lipskin addressable market by three times and doubles addressable missile solutions while providing opportunities to cross sell solutions to existing space customers. I will now turn the call over to Ademir to discuss our financial performance in greater detail.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Thank you, David, and good morning, everyone. Let's turn to Slide six, third quarter twenty twenty five summary. On a consolidated basis, total revenue increased approximately 17.2% year on year to $207,800,000 This reflected a 26.3% benefit from recent acquisitions, partially offset by an organic revenue decline of 8.11% impact from foreign exchange. Third quarter twenty twenty five adjusted operating margin increased two eighty basis points year on year to a record 19.4. In the fiscal third quarter, adjusted operating income increased 37.3% on 17.2% consolidated revenue increase year on year.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Adjusted earnings per share increased 3.7% year on year to $1.95 Net cash provided by operating activities was $9,600,000 in the third quarter of fiscal twenty twenty five, compared to $24,400,000 a year ago. Capital expenditures were $6,100,000 compared to $5,200,000 a year ago. As a result, we generated fiscal third quarter free cash flow of $3,500,000 compared to $19,300,000 a year ago. Our fiscal third quarter cash flow was impacted by one time transaction related payments, certain annual tax payments, a longer customer credit terms related to recent acquisitions that affected cash conversion in the quarter. Now please turn to Slide seven and I will begin to discuss our segment performance and outlook beginning with Electronics.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Segment revenue of $111,300,000 increased 38.4% year on year as 48.1 percent benefit from acquisitions was partially offset by an organic decline of 8.90.8% impact from foreign currency. Adjusted operating margin of 29.8% in fiscal third quarter twenty twenty five increased seven sixty basis points year on year as the contribution from recent and Orion Group acquisition productivity initiatives and product mix were partially offset by lower core volume. Excluding recent Amarin and Orion Group acquisition, our new business opportunity funnel increased approximately 50% year on year to $117,000,000 Further progress of our operational and commercial excellence initiatives drove commercial expansion in India, increased activity in the test and measurement end markets supported by AI and data center expansion and higher activity and demand in mill arrow end market. Our book to bill in fiscal third quarter was 0.98 with orders of approximately $109,000,000 driven by stable orders in core businesses and contribution from Amarin Group acquisition, which had a book to bill of 1.04. Organic bookings increased over 10% year on year.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Since our products are customized in nature, our bookings take longer to convert into revenue, but with stronger margins. As David mentioned, our expansion plans for Amarin Orion within The U. S. And India are well underway to support additional demand. In addition, we are working on our greenfield site in Europe that should be operational within six months.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Sequentially, in fiscal fourth quarter twenty twenty five, we expect slightly higher revenue and similar to slightly higher adjusted operating margin driven by the Amarin and Orion group acquisition, higher sales into fast growth end markets and price realization, partially offset by higher tariff costs and continued strategic growth investments. Please turn to Slide eight for a discussion of the Engraving and Scientific segments. Engraving revenue decreased 15.7% to $30,600,000 driven by organic decline of 12.6% and a 3.1% impact from foreign currency. Adjusted operating margin of 11.2% in fiscal third quarter twenty twenty five decreased seven twenty basis points year on year due to lower revenue. In our next fiscal quarter on a sequential basis, we expect slightly higher revenue and moderately higher adjusted operating margin due to more favorable project timing in Asia, slightly improved demand in North America and Europe, and realization of previously announced restructuring actions.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

To address the continued softness in end markets served by this segment, our previously announced restructuring actions are underway and are projected to yield over $4,000,000 in annualized savings once fully implemented. Scientific revenue increased 8.1% to $18,300,000 due to 16.1% benefit from recent acquisition partially offset by an organic decline of 8%, primarily due to lower demand from academic and research institutions that were impacted by NIH funding cuts. Adjusted operating margin of 22.6% decreased seven eighty basis points year on year due to organic decline and product mix as a result of the acquisition. Sequentially, we expect slightly lower revenue and adjusted operating margin due to soft demand from academic and research institutions affected by NIH funding cuts and higher tariff costs. To counteract the impact of higher tariff costs, we plan to implement pricing and productivity initiatives while continuing to optimize our supply chain to alternate sources.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Now turn to Slide nine for a discussion of the Engineering Technologies and Specialty Solutions segment. Engineering Technologies revenue increased 36.2% to $27,400,000 driven by 26.3% benefit from recent Nexstar White acquisition and organic growth of 9.9%. This strong organic growth was due to more favorable project timing in the space and market and growth in sales from new products. Adjusted operating margin of 18.6% increased 110 basis points year on year due to contribution from recent acquisition and higher volume. Sequentially, we expect similar to slightly higher revenue and similar adjusted operating margin.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Specialty Solutions segment's revenue of $20,200,000 decreased 13.9% year on year, primarily due to general market softness. Operating margin of 16.2% decreased three seventy basis points year on year. Sequentially, we expect moderately higher revenue and operating margins. Next, please turn to Slide 10 for a summary of Standex's liquidity statistics and the capitalization structure. Our currently available liquidity is approximately $170,000,000 At the end of the third quarter, Standex had net debt of $470,400,000 compared to 10,000,000 at the end of fiscal third quarter twenty twenty four.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Our leverage ratio per our bank credit agreement currently stands at 2.8. In fiscal fourth quarter twenty twenty five, with the addition of MaxTylerite, we expect interest expense to be approximately $9,000,000 Sanex's long term debt at the end of fiscal third quarter twenty twenty five was $580,200,000 Cash and cash equivalents totaled $109,800,000 We declared our two hundred and forty third quarterly consecutive cash dividend of $0.32 per share and approximately 6.7% increase year on year. In fiscal twenty twenty five, we expect capital expenditures to be between 25,000,000 and $30,000,000 Relative to our debt leverage, we will continue to focus on paying down debt and anticipate that our leverage ratio will further improve at the end of the fourth quarter and will continue to decline to twenty twenty six as we announced with our acquisition of Amarin Orion Group. I will now turn the call over to David for concluding remarks.

[David Dunbar, Chairman, President & CEO at Standex International]

Thank you, Adameer. Please turn to Slide 11. I'm very proud of our team for their continued operational execution and for the success of our recent acquisitions, both of which helped us achieve record adjusted operating margin for a second consecutive quarter. Sales into fast growth end markets are well on track for fiscal year twenty twenty five expectation of approximately $170,000,000 This was primarily driven by growth in data center demand and grid modernization and expansion. Outside of the electrical grid, we are seeing growth in commercialization of space, defense applications and renewable energy end markets.

[David Dunbar, Chairman, President & CEO at Standex International]

To support our future growth, we continue to invest in new product development and new applications across markets with growth potential. We have released 13 new products year to date and new products are now expected to contribute over 200 basis points of incremental growth this fiscal year. While we cannot predict the impact of new tariffs on global trade and economic growth, our regional presence, strong customer relationships and our disciplined approach to pricing and productivity actions position us well to manage through the current and short term challenges. Most of our supply chain is strategically located to service regional demand, with China imports to The U. S.

[David Dunbar, Chairman, President & CEO at Standex International]

Representing approximately 6% of the cost of goods sold. We plan to continue to invest in our key strategic priorities while implementing additional productivity actions and select price increases and working to optimize our supply chain to mitigate the impact of tariffs. We remain on track to achieve our fiscal twenty twenty eight long term targets of sales of greater than $1,150,000,000 adjusted operating margin of greater than 23% and ROIC of greater than 15.5%. We remain confident in our ability to pay down debt and reduce our net leverage ratio. We will now open the line for questions.

[Operator]

Thank you. With that, our first question comes from the line of Chris Moore with CJS Securities. Please go ahead.

[Chris Moore, Senior Analyst at CJS Securities]

Hey. Good morning, guys. Thanks for taking a couple.

[Chris Moore, Senior Analyst at CJS Securities]

Alright.

[David Dunbar, Chairman, President & CEO at Standex International]

Good morning.

[Chris Moore, Senior Analyst at CJS Securities]

Good morning. Maybe we'll start with with tariffs. So 6% of COGS imported from China. Is that mostly scientific and hydraulics?

[David Dunbar, Chairman, President & CEO at Standex International]

Yes. So that it's split in about three parts almost equally, about one third of that goes into electronics, one third into specialty and the remaining third into scientific.

[Chris Moore, Senior Analyst at CJS Securities]

Got it. So and I guess the two primary, one is looking for alternative sources and two is pricing. Is pricing power you have a little more pricing power in one of those splits? Or how do you look at that?

[David Dunbar, Chairman, President & CEO at Standex International]

That's a great question because it does vary business by business. So within electronics and specialty, we think because of the significance of the bill of materials, the relationship with customers, and the overall value proposition, we're confident we cover the China tariffs with price productivity actions working with customers. Scientific is a little bit different. Now you have to assume what will happen with tariffs. If the China tariffs stay where they're at right now, it's 145% on China, we think we can scientifically cover about 70% of that incremental tariff with price and productivity.

[David Dunbar, Chairman, President & CEO at Standex International]

And then longer term would have to look at some changes in supply chain and product design. It would take about a year to make up the rest of that.

[Chris Moore, Senior Analyst at CJS Securities]

Got it. Very helpful. Right. So it doesn't look like Q4 will show any organic growth. I guess on just the puts and takes for organic growth in fiscal twenty twenty six is obviously, visibility isn't where you'd like it to be at this point.

[Chris Moore, Senior Analyst at CJS Securities]

But is that more of a back half conversation? Or just any thoughts there at this stage?

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Well, hey. Good morning, Chris. It's Adam here. I think I think if if you if you look at electronics specifically, know, we are very pleased with the order intake rates in a core business we are seeing over the last couple of quarters. And obviously, Amarin Orion has been a phenomenal acquisition for us, albeit it's not organic yet.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

So as we enter FY 2026, we do again assuming current economic environment and you know, nothing significant, no significant changes, we do believe we're going to start seeing organic growth, you know, and electronics is always our engine, you know, as far as the other businesses, you know, engineering technology group, very robust order book, you know, very strong end markets, we feel very, very confident that they will continue to show organic growth. And then Engraving, frankly, is coming from a very low starting point at this stage with the auto market in North America being an all time low. So there's a possibility and we feel that we'll be able to turn the tide there as well. Scientific remains a little bit of a challenge because of what David just described. And that specialty has been, you know, we feel pretty good about specialty, you know, as far as the organic growth, is concerned as well.

[David Dunbar, Chairman, President & CEO at Standex International]

I guess another way to look at it, because you've mentioned both Q4 and upcoming quarter and the rest of the year. If you just zoom out a little bit and think about what's driving growth long term in the portfolio, Those things that we're confident in that we know we can control. So the fast growth markets, Amarin Orion alone, if it continues its growth, will add about $20,000,000 of sales to the company over a year. That's over two points of growth. Our new products are running ahead of what we had said earlier this year, just over about 200 basis points of growth.

[David Dunbar, Chairman, President & CEO at Standex International]

So that's 400 basis points mostly from all the investments and movements we've made in the last few years to focus more on organic growth. And now you have to make assumptions about underlying market. If you assume no recession and say we return to say 2.5% GDP, on top of that, we typically get about a point of price in normal times. So you add those all up, making assumptions about the end market that are at a bookend or both expectations.

[Chris Moore, Senior Analyst at CJS Securities]

Got it. That's very helpful. Maybe just the last one on Ameren Narayan. The planned expansion, it sounds like you said about six months before you start selling in Europe. Just is there a significant investment required to begin there or just kind of what the primary kind of milestones are over the next two quarters?

[David Dunbar, Chairman, President & CEO at Standex International]

Yes. Thank you for that question. We're very excited about this. Europe is actually the biggest end market for their products. It's over a $2,000,000,000 market, whereas America is about $1,000,000,000 And they have served European OEMs out of India.

[David Dunbar, Chairman, President & CEO at Standex International]

And I think we announced even when at the acquisition, those OEMs have been asking them to create a footprint in Europe. So the last quarter, we've made several trips to Europe. We're working we're progressing rapidly. And this will go in stages. So the initial stages, the investment will not be significant.

[David Dunbar, Chairman, President & CEO at Standex International]

We just we obviously need a building. We'll start stocking and doing some testing and then gradually add equipment. So in the first year or two, maybe $1,000,000 2 million dollars of investment. And then as it grows, we will expand it from there.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Yes, Chris. It's not a very high capital investments required for us to get it started. So there should be a lot of cash outflows there.

[Chris Moore, Senior Analyst at CJS Securities]

Perfect. Alright, guys. Thanks. I'll leave it there.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Thank you.

[Operator]

And your next question comes from the line of Matt Cranda with Roth Capital. Please go ahead.

[Matthew Koranda, MD & Senior Research Analyst at Roth Capital Partners, LLC]

Hey, guys. Good morning. Just continuing on with the electronics questioning. So Ameren or Ryan, the order trend looks pretty encouraging. Just wanted to see if maybe you could unpack the end markets that are driving strength for them between data center or some of the electrical grid infrastructure expansion.

[Matthew Koranda, MD & Senior Research Analyst at Roth Capital Partners, LLC]

And then could you talk about capacity utilization there right now? It sounds like I would imagine we're running quite high given that we're going to be adding a plant in Europe. And so what does capacity utilization look like right now? Is there a hit to margins as you kind of ramp the new plant in Europe? Maybe just talk about the transition there over the next couple of quarters.

[David Dunbar, Chairman, President & CEO at Standex International]

Yes. So first of all, the sources of growth are more or less what they were when we announced the acquisition. You've got grid modernization in all parts of the world. There's expansion of electrical capacity just to support growth economic growth and living standards. Data centers and artificial intelligence are driving investments.

[David Dunbar, Chairman, President & CEO at Standex International]

So we're not seeing any change in that momentum. Our relationships are with the large electrical equipment OEMs. They still have demand that goes out several years. So we see no change in those drivers for the growth. Our capacity we still have capacity in our current plants and we're probably running, I don't know, 60%, seventy % capacity.

[David Dunbar, Chairman, President & CEO at Standex International]

We recently added second shifts in India and in Texas. But we also announced in the script, we will expand in India. We'll add footprint, we'll expand in The U. S, we'll add footprint and we have the greenfield site coming in Europe. We have good visibility to the demand from customers.

[David Dunbar, Chairman, President & CEO at Standex International]

And so that capacity will come online in time to meet that demand.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Yes. And Matt, if I can add this from a margin standpoint, we don't anticipate that the margins in Europe will be any different than the margins of the consolidated group as they stand today.

[Matthew Koranda, MD & Senior Research Analyst at Roth Capital Partners, LLC]

Okay. Very clear. I appreciate that. And then maybe just on the core order book in electronics. I think you guys mentioned kind of flattish in terms of order trend quarter over quarter.

[Matthew Koranda, MD & Senior Research Analyst at Roth Capital Partners, LLC]

What does that mean for sort of when we inflect to the positive in terms of organic growth in the electronic segment? How soon could that come? What would that look like over the next couple of quarters?

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Yeah. I mean, you know, and the other thing that I just want to mention, you know, we are about 10% up organically on the on orders in electronics, if you look at the year on year. So, know, we are kind of at that inflection point now, to be quite honest with you. And as we move into the next fiscal year, which would be, you know, our fiscal first quarter FY 2026 next quarter, we feel we are turning the corner and we should start showing organic growth.

[Matthew Koranda, MD & Senior Research Analyst at Roth Capital Partners, LLC]

Okay, great. And then maybe just the last one, if I could. Thinking about the sort of the overall deposition here, What are your thoughts on sort of leverage and where we'd be willing to take it if we found an attractive acquisition over the next few quarters? Or I guess, we think about sort of leverage as coming down over the next few quarters, and we're driving cash to delever the balance sheet with the macro uncertainty that we're dealing with. Just wanted to hear your thoughts on that front.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Yes. So, Matt, our leverage as it stands today is about our bank facility is about 2.8. If you kind of annualize our fourth quarter EBITDA, it's less than that. It's about 2.5, two point six. Obviously, priority is to pay down debt.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

And we also have a lot of very exciting organic initiatives that David has just been talking about specifically in electronics and some other businesses. So our priority would be to invest in organic growth and the things we know the best and we control. And then at the same time and obviously work down to pay down the debt and take leverage down. And we think we're going to make a dent in leverage this quarter. We're to continue to work it through FY twenty twenty six.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

And we are very good cash generating company and we'll continue to focus on both organic growth investments as well as paying down the debt.

[David Dunbar, Chairman, President & CEO at Standex International]

Yes, let me add something. I just from a philosophical standpoint, I guess we're about as high in leverage as we'd like to be. We are still in the market. A lot of the acquisitions that we make are based on years and years of relationship building. So we continue to do that And in the next year or so, we'll be at a leverage point we could consider.

[Matthew Koranda, MD & Senior Research Analyst at Roth Capital Partners, LLC]

Okay. Got it. Thanks, guys. Appreciate it.

[Operator]

And your next question comes from the line of Davidson. Please go ahead.

[Michael Shlisky, Managing Director & Senior Equity Research Analyst at D.A. Davidson]

Good morning. Thanks for taking my questions here. So leverage at 2.8 sounds like it's coming down. That's certainly good to hear. Besides just rolling in Ameren Narayan and the Maxtarla EBITDA into the numbers that you just implied, Adameer, do you have any other levers that you're looking to pull on the debt side?

[Michael Shlisky, Managing Director & Senior Equity Research Analyst at D.A. Davidson]

I mean, I wasn't sure if you needed to or could liquidate any working capital in the near term, or if you even have to. Just curious as to how you feel about other parts of your balance sheet at the current time.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Yeah. Now look, we certainly have some opportunities in our working capital metrics. As an example, some of the businesses we recently acquired generally have a longer credit terms with some of their customers. Those credit terms are sometimes over ninety days. So we will be working with with, you know, our our new acquisitions as well as the customers to try to to improve those terms and get them a little bit more balanced, if you will.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

So we clearly have opportunity on on receivables. We'll obviously continue to manage manage inventory as well. So, yeah, I mean, there's clearly an opportunity to get more operating cash flow in the upcoming quarters and we plan to do that.

[Michael Shlisky, Managing Director & Senior Equity Research Analyst at D.A. Davidson]

Great. I also wanted to circle back to some of your answers and comments on tariffs earlier. Given that Scientific is at this point such a small part of the overall company in China, the China part of it is even smaller, of course. And the other things that you mentioned in the other segments, it feel like the total potential impact from the tariffs that you're seeing today, barring anything changing going forward, is pretty de minimis? And would you agree with the thought that maybe the efforts you have to take to mitigate it through pressing and productivity is relatively minor.

[Michael Shlisky, Managing Director & Senior Equity Research Analyst at D.A. Davidson]

It doesn't seem all that challenging at this point. This just doesn't sound like you're in any kind of concern or huge panic here at all.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Yeah, I think that's fair way to summarize it, Mike. But obviously, you know, it's up do the best we can to continue maintaining good relationship with suppliers, with customers, and obviously to protect our margins. But yeah, I mean, in a grand scheme of things, it's not, again, as David said, we are in the region for the region for the most part in terms of our supply chain as well as customer relationships. So yeah, the impact for us is not certainly not significant.

[David Dunbar, Chairman, President & CEO at Standex International]

We laid it out pretty clearly early that of that 6% is about 10,000,000, 10 million, 10 million, just the 10,000,000 of scientific that's going to require some more. So it's not to minimize the work that they have to do. So in that business, there's plenty of work, but they've got line of sight to actions to contain that as I described earlier.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

It's our job to worry, Mike, right?

[David Dunbar, Chairman, President & CEO at Standex International]

But no, you're right. Overall impact at a corporate level, de minimis.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

That's correct.

[Michael Shlisky, Managing Director & Senior Equity Research Analyst at D.A. Davidson]

Okay, great. And I want to turn to some of your comments you made on the new products that are kind of in the process of rolling out from fiscal twenty twenty five. But at this point, fiscal twenty twenty six starts in just two months from now. Can you maybe just share with us yeah, so could you maybe just share with us some of your plans for new products during 2026? Could it be on the same order of magnitude as 2025?

[Michael Shlisky, Managing Director & Senior Equity Research Analyst at D.A. Davidson]

And also, there a tailwind from stuff that got introduced during 2025 that still has to lap in 'twenty six or has ongoing adoption that will be beyond just more organic growth next year?

[David Dunbar, Chairman, President & CEO at Standex International]

Yeah, are great questions. I think we've talked before that because of our business model and our products are sold to OEMs who are incorporating that into their generation platforms. It typically takes about three years for any application, any new opportunity we're going to ramp to full volume. So that's true of new products as well as just the applications of our existing products. So everything released this year will continue to ramp in the coming years.

[David Dunbar, Chairman, President & CEO at Standex International]

We also have a pipeline that we would expect order of magnitude, same number of products to be released in FY '20 '20 '6 as in FY '20 '20 '5.

[Michael Shlisky, Managing Director & Senior Equity Research Analyst at D.A. Davidson]

Outstanding. I'll pass it along. Thank you.

[Operator]

And your next question comes from the line of Ross Perrinblack with William Blair. Please go ahead.

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

Hey. Good morning, gentlemen.

[David Dunbar, Chairman, President & CEO at Standex International]

Hey, Ross.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Hey, Ross.

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

Hey, guys. Just kicking off with Core Electronics. Can you maybe just update us on where we are with, the broader restocking phase? And what's underwriting confidence for a return to growth in 2026 on the organic side just against the core business?

[David Dunbar, Chairman, President & CEO at Standex International]

Yes. So if you look at the underlying business, we're seeing strength in Asia. North America is ticking up. Europe remains soft. Most of the stocking destocking impact was in Asia and China for us.

[David Dunbar, Chairman, President & CEO at Standex International]

And that is a few quarters ago, we said it was bottoming out. That's picking up.

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

Okay. Well, then maybe just help us size the automotive and general industrial exposure again. Trying to think about the ebb and flow of China picking up with North America and Western Europe getting a little weaker there, at least on the auto side.

[David Dunbar, Chairman, President & CEO at Standex International]

What's question? You mean auto exposure?

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

Yeah,

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

and general industrial because those were both noted as being weaker again this quarter.

[David Dunbar, Chairman, President & CEO at Standex International]

Historically, just thinking out loud here, auto has been about 20% of the electronics business, a little lower now just because it's been soft. Yes, it's been more like 15% in recent quarters. So EVs have been flat. Other combustion engine has declined. It's over about 15% of total electronics.

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

And then just on the scientific side,

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

can you

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

just maybe help us frame the risk here from the NHI funding? I mean, based off last quarter, it looks like a couple million and that probably counts for the next, you know, three quarters going forward. And then I believe on the, you know, pharmacy side, that's pretty much at trough. Are you seeing any signs of recovery there?

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Yeah, I think Ross for the NIH, think you just sized it pretty well in terms of the potential impact. Yeah, and you know, for the for the pharmacies, you know, yeah, you're right. It's kind of at the trough. We are waiting to see if the new capital equipment requests are gonna come in. You know, maybe some of that is a little bit impacted now with some of the economic uncertainty.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

But certainly, those units that we placed years ago are due to be replaced. And, you know, we do expect we're gonna see some uptick in the near future.

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

I mean, are you having active conversations there?

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Is

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

this Yes.

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

Two key players. Right? Okay. That's good to hear.

[David Dunbar, Chairman, President & CEO at Standex International]

Yes.

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

And then maybe just one last one on the. Can you call out the major programs there? You noted wide bodies. Is there any Boeing exposure, Airbus? Anything we can point to?

[David Dunbar, Chairman, President & CEO at Standex International]

Yeah, both. So both Boeing and Airbus. On the wide body programs with both those players.

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

All right. I mean, is this primarily sole source, single source? For what they offer?

[David Dunbar, Chairman, President & CEO at Standex International]

Yeah.

[David Dunbar, Chairman, President & CEO at Standex International]

Yes. Yeah.

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

Awesome.

[Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C]

Alright. Thank you, guys.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Yeah. Thanks. Thanks, Ross.

[Operator]

And your next question comes from the line of Gary Pristopino with Barrington Research. Please go ahead.

[Gary Prestopino, Managing Director at Barrington Research Associates]

Hi. Good morning, Couple of questions here. The guidance that you gave us for Q4, in terms of the organic decline, is it going to be very similar to the organic decline in sales that you saw in Q3?

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Hey, good morning, Gary. No, it will not, because we do believe electronics will, which is again our engine will do better than they have done in Q3. So we should see some improvement there. You know, the only one that I would point to that might be a little soft, you know, from kind of a comparison would be would be obviously scientific for the reasons we just we just spoke about. But yeah, we do expect that.

[Gary Prestopino, Managing Director at Barrington Research Associates]

No, you know, when you say sequentially up and I'm just, you know, back of the envelope, know, Amron, let's say it's you bought it, it had a hundred million of revenues, you had 25 there, McStarlight about 8,000,000, that's $33 So, I'm just trying to get an idea of when you're talking about the changes you're seeing in or contemplating or the growth you're contemplating just what we have to work off there. So we really shouldn't be looking at about an 8% organic decline in Q4 as we saw in Q3.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

No,

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

no, no.

[Gary Prestopino, Managing Director at Barrington Research Associates]

Okay,

[Gary Prestopino, Managing Director at Barrington Research Associates]

that's good to hear. I just want to ask in terms of fast growth markets, were your sales last quarter about $26,000,000 I think I went back and looked at that and you were about $60,000,000 this year. Is that kind of correct or this quarter?

[David Dunbar, Chairman, President & CEO at Standex International]

Yeah, that's right. The '26 you quoted, what period were you referring to?

[Gary Prestopino, Managing Director at Barrington Research Associates]

I was looking at last year's Q3.

[David Dunbar, Chairman, President & CEO at Standex International]

Yes, yes, that's right. Yes, and you recall this last quarter, kind of bridged kind of a recasting. We have an old number, new number because the Amarin and Orion sales are all into fast growth. So we're including that in the 60 of course.

[Gary Prestopino, Managing Director at Barrington Research Associates]

Right. So I guess, phrase the question this way, given that Amaron had a pretty good margin profile. How has that changed the margin profile, adjusted operating margin profile of your sales in the fast growth markets? Could you give us an idea of the magnitude or the basis point increase year over year?

[David Dunbar, Chairman, President & CEO at Standex International]

Let's see. Well, yes. So that's a great question. Our margins into fast growth markets have always been higher than our average margins. They tend to be newer products.

[David Dunbar, Chairman, President & CEO at Standex International]

There's a great value proposition. The Amarin and Orion margins still are higher than that average. So it's about half of our it probably has a couple of hundred basis points to grow fast growth margins.

[Gary Prestopino, Managing Director at Barrington Research Associates]

Okay, a couple of hundred basis points. So as this grows, it's going to become very accretive.

[David Dunbar, Chairman, President & CEO at Standex International]

Yeah. Okay.

[Gary Prestopino, Managing Director at Barrington Research Associates]

And then lastly, on the one of the things you mentioned was the tariffs. You say you can offset some of this with price increases. I realize this is rather de minimis relative to other companies, but have you informed your customers that you're going to increase prices as of yet? I just want to get what's kind of been their reaction to that?

[David Dunbar, Chairman, President & CEO at Standex International]

It runs across the board. Mean, we have all the spectrum of reactions. But there are hundreds or thousands of discussions going on with customers in many of our businesses about price increases. So I guess the bottom line is what we conveyed earlier. Think we can cover to the extent we can cover the tariffs.

[David Dunbar, Chairman, President & CEO at Standex International]

The one challenge is going to be in the scientific business based on the competitive nature of that market and their ability to get price. And all the other businesses, combination of price and productivity will cover tariffs.

[Ademir Sarcevic, VP, CFO & Treasurer at Standex International]

Yes. Gary, are not just approaching this purely from a We're looking at productivity, you know, sourcing savings as well. So, you know, and and then the way we approaching this with our customers, you know, we are kind of all in this together, and we're gonna come up with the best optimal solution for, you know, for for us as well as for our customers. So it's a combination really of three things, pricing, productivity, and sources of supply.

[Gary Prestopino, Managing Director at Barrington Research Associates]

Well, let me ask you this. With your existing sources right now, where are they coming from say China and India? Can you go back to them and say, hey, you guys got to share some of this burden? I mean, what you're getting out of China, is that coming out of Mainland China or Taiwan?

[David Dunbar, Chairman, President & CEO at Standex International]

Well, 6% we quoted is Mainland China. And so we have there again, you've had discussions with all the suppliers. Some of them have participated a bit, I guess, with others. Others have not. It just depends on the business and the supplier.

[Gary Prestopino, Managing Director at Barrington Research Associates]

Okay.

[Gary Prestopino, Managing Director at Barrington Research Associates]

That's it. Thank you very much.

[David Dunbar, Chairman, President & CEO at Standex International]

Thank you, Jerry.

[Operator]

And we have no further questions at this time. I would like to turn it back to David Dunbar for closing remarks.

[David Dunbar, Chairman, President & CEO at Standex International]

All right. I want to thank everybody for joining us for this call. We always enjoy reporting on our progress at Standex. And finally, again, I want to thank our terrific employees for their hard work, continued support of our strategic objectives and delivering another solid quarter. And thank you for the shareholders for your continued support and contributions.

[David Dunbar, Chairman, President & CEO at Standex International]

We look forward to speaking with you again in our fiscal fourth quarter twenty twenty five call.

[Operator]

Thank you, presenters. And ladies and gentlemen, this concludes today's conference call. Thank you all for participating. You may now disconnect.

Participants

Executives

• Christopher Howe, Director of Investor Relations
• David Dunbar, Chairman, President & CEO

Analysts

• Ademir Sarcevic, VP, CFO & Treasurer at Standex International
• Chris Moore, Senior Analyst at CJS Securities
• Matthew Koranda, MD & Senior Research Analyst at Roth Capital Partners, LLC
• Michael Shlisky, Managing Director & Senior Equity Research Analyst at D.A. Davidson
• Ross Sparenblek, Equity Research Analyst at William Blair & Company, L.L.C
• Gary Prestopino, Managing Director at Barrington Research Associates